Relmada Therapeutics, Inc.

Bank of New York Mellon Corp RLMD

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/6/2026

Shares

295,623

Value ($000)

2,046

Weight

0.0%

2019 Q4 - 2026 Q2 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/6/2026	2,046	0.0%	295,623	6/30/2026
2023 Q4	1/29/2024	46	0.0%	11,198	12/31/2023
2023 Q3	10/24/2023	110	0.0%	36,719	9/30/2023
2023 Q2	8/3/2023	195	0.0%	79,428	6/30/2023
2023 Q1	5/9/2023	347	0.0%	153,503	3/31/2023
2022 Q4	2/14/2023	650	0.0%	186,162	12/31/2022
2022 Q3	11/14/2022	7,955	0.0%	214,876	9/30/2022
2022 Q2	8/15/2022	4,596	0.0%	242,019	6/30/2022
2022 Q1	5/11/2022	6,397	0.0%	237,013	3/31/2022
2021 Q4	2/11/2022	4,796	0.0%	212,862	12/31/2021
2021 Q3	11/18/2021	5,188	0.0%	197,934	9/30/2021
2021 Q2	8/11/2021	6,374	0.0%	199,124	6/30/2021
2021 Q1	5/13/2021	6,674	0.0%	189,544	3/31/2021
2020 Q4	2/9/2021	5,295	0.0%	165,119	12/31/2020
2020 Q3	11/12/2020	6,677	0.0%	177,499	9/30/2020
2020 Q2	8/12/2020	5,926	0.0%	132,431	6/30/2020
2020 Q1	5/6/2020	3,348	0.0%	98,144	3/31/2020
2019 Q4	2/14/2020	4,002	0.0%	102,614	12/31/2019